Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy

Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy

Despite the availability of molecularly targeted agents for advanced hepatocellular carcinoma (aHCC), these are limited to compensated cirrhotic patients, and concerns about decreased hepatic functional reserve (HFR) and unknown adverse events, which may affect long-term survival, remain unaddressed...

Full description

Bibliographic Details
Main Authors: Kei Moriya, Tadashi Namisaki, Hiroaki Takaya, Kosuke Kaji, Hideto Kawaratani, Naotaka Shimozato, Yasuhiko Sawada, Akitoshi Douhara, Shinya Sato, Masanori Furukawa, Koh Kitagawa, Takemi Akahane, Hitoshi Yoshiji
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Journal of Clinical Medicine
Subjects:
hepatocellular carcinoma
hepatic arterial infusion chemotherapy
molecularly targeted therapies
hepatic functional reserve
des-gamma-carboxy prothrombin
Online Access:https://www.mdpi.com/2077-0383/10/4/629

Internet

https://www.mdpi.com/2077-0383/10/4/629

Similar Items